Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice

Author(s): Dhir A, Naidu PS, Kulkarni SK


Brain cyclooxygenases (COX), the rate-limiting enzyme in prostaglandin synthesis, is rapidly and transiently induced by convulsions in hippocampal and cortical neurons. Previous studies have explored the protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) against chemical kindling in mice. With this background, the present study was designed to explore the possible effect of nimesulide (a preferential COX-2 inhibitor) against pentylenetetrazol (PTZ)-induced kindling epilepsy in mice. To induce kindling, PTZ was injected in a subconvulsive dose (40 mg/kg, i.p.) every other day for 15 days. Nimesulide (2.5 or 5 mg/kg, p.o.) was administered each day 45 min before either PTZ or vehicle challenge. The intensity of kindling was assessed immediately after PTZ administration according to a prevalidated scoring scale. On 16th day i.e. 24 h after the last dose of PTZ, animals were sacrificed and various biochemical parameters were assessed in the whole brain. Compared with normal control group, PTZ-kindled mice had significantly higher levels of malondialdehyde, nitrite, myeloperoxidase but had lower levels of reduced glutathione in the whole brain homogenate. Chronic treatment with nimesulide (2.5 or 5 mg/kg, p.o.) for 15 days showed significant decrease in kindling score and could play a role in controlling the accompanying biochemical alterations due to PTZ. These results suggested that nimesulide, a preferential COX-2 inhibitor offered neuroprotection against PTZ-induced kindling in mice.

Similar Articles

Modulation of pentylenetetrazole-induced kindling and oxidative stress by curcumin in mice

Author(s): AgarwalNB, Jain S, Agarwal NK, Mediratta PK, Sharma KK

Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy

Author(s): Frantseva MV, Perez Velazquez JL, Tsoraklidis G, Mendonca AJ, Adamchik Y, et al.

Role of oxidative stress in epileptic seizures

Author(s): Shin EJ, Jeong JH, Chung YH, Kim WK, Ko KH, et al.

Immunomodulatory effects of fenugreek (Trigonellafoenumgraecum L

Author(s): Hafeez BB, Haque R, Parvez S, Pandey S, Sayeed I, et al.

A review on pharmacological and analytical aspects of diosgenin: a concise report

Author(s): Patel K, Gadewar M, Tahilyani V, Patel DK

In vivo and in vitro studies of hypocholesterolemic effects of diosgenin in rats

Author(s): Juarez-Oropeza MA, Diaz-Zagoya JC, Rabinowitz JL

Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice

Author(s): Patil SP, Jain PD, Sancheti JS, Ghumatkar PJ, Tambe R, et al.

Kindling-induced learning deficiency and possible cellular cellularand molecular involved mechanisms

Author(s): Sherafat MA, Ronaghi A, Molaei L, Nejadhoseynian M, Ghasemi R, et al.

Piracetam prevents pentylenetetrazol kindling-induced neuronal loss and learning deficits

Author(s): Pohle W, Becker A, Grecksch G, Juhre A, Willenberg A